Escrito por estudiantes que aprobaron Inmediatamente disponible después del pago Leer en línea o como PDF ¿Documento equivocado? Cámbialo gratis 4,6 TrustPilot
logo-home
Document preview thumbnail
Vista previa 2 fuera de 15 páginas
Examen

NR 546 Psychopharmacology for the Psychiatric-Mental Health Nurse Practitioner MidTerm Exam Test 2026: 90+ Questions & verified Answers | Graded A+ | Guaranteed Pass!!

Document preview thumbnail
Vista previa 2 fuera de 15 páginas

CONQUER YOUR NR 546 MIDTERM WITH 100% VERIFIED ANSWERS! GUARANTEED A+! Stop stressing and start passing! This comprehensive study guide contains 95 meticulously curated questions with the correct answers clearly identified, covering every critical topic you'll face on the NR 546 Psychopharmacology midterm. It's your ultimate shortcut to mastering the material and securing a top grade. This isn't just a random collection of questions—it's a strategic review of the most heavily tested concepts that professors love to include on exams. Here's what you'll master: Neuroanatomy & Brain Function: Know exactly which lobe controls movement and intelligence (Frontal Lobe), which region handles speech comprehension (Wernicke's Area), and the role of the hippocampus in memory and anxiety. Understand what happens when specific brain areas are damaged. Neurotransmitters & Pathways: Get crystal clear on dopamine's role in Parkinson's and schizophrenia, the "happy hormone" (serotonin/5HT), GABA as the chief inhibitory neurotransmitter, and the four major NTM categories. Plus, master the mesolimbic, mesocortical, and tuberoinfundibular pathways—and exactly which symptoms and side effects they're associated with (positive symptoms, hyperprolactinemia, etc.). Antipsychotics—FGA vs. SGA: Learn the difference between first-generation (typical) and second-generation (atypical) antipsychotics. Know which medications carry the highest risk for hyperprolactinemia and galactorrhea (Risperidone), which is best for insomnia and is the best-tolerated antipsychotic (Olanzapine), and which requires monitoring for rash (Ziprasidone/Geodon). Understand EPS, tardive dyskinesia, akathisia, dystonia, and neuroleptic malignant syndrome inside and out. Pharmacokinetics & Pharmacodynamics: Master the critical concepts of agonists, partial agonists, inverse agonists, and antagonists. Understand the difference between a CYP450 inducer and inhibitor, and know the classic examples of each (e.g., amiodarone, sulfonamides = inhibitors; carbamazepine, rifampin, alcohol = inducers). Learn how smoking affects antipsychotic metabolism and why grapefruit juice is a danger. Clinical Decision-Making: This guide teaches you how to apply pharmacology to real patient scenarios. Learn how to adjust doses based on smoking status, manage drug interactions (like amiodarone and olanzapine), interpret pharmacogenomic testing, recognize SSRI discontinuation syndrome (and why fluoxetine is the solution), and understand when to draw an ammonia level for a patient on valproic acid. Why this is your #1 study tool: Each question is designed to test your clinical reasoning, and every answer is verified and graded A+. This guide transforms complex pharmacology into simple, memorable facts. You'll learn not just what the answer is, but why it's correct, building the deep understanding you need to ace the exam and excel in clinical practice. Don't gamble with your grades. This is the fastest, most efficient way to prepare for the NR 546 midterm. Invest in your success and guarantee your pass!

Vista previa del contenido

NR 546 MIDTERM EXAM TEST 2026: 90+ QUESTIONS AND 100% VERIFIED
ANSWERS | GRADED A+ | GUARANTEED PASS!!

1. Which of the following data is most accurate in determining a treatment plan for a
patient who presents with depression? ANS: The patient states that they are experiencing
feelings of sadness, insomnia, and lack of appetite

2. Informed Consent ANS: clients have the right to receive enough information to
make decisions about their treatment. They must also be informed about the potential
risks associated with medication. Clients have the right to refuse treatment and cannot
be forcibly medicated in non-emergencies.


3. Which lobe is responsible for movement and intelligence and can result in
personality changes if damaged? ANS: Frontal Lobe

4. The PMHNP wants to prescribe olanzipine for a client with depression. However, the
client currently takes amiodarone for chronic atrial fibrillation. What does the PMHNP
need to do to establish efficiency of this medication? ANS: Decrease the dosage of
olanzipine

Amiodarone is a CYP450 inhibitor which means it will stop/slow down the olanzapine from
metabolizing in the body.
Therefore, the olanzapine is at risk for building up in the client's system rather than being
metabolized and secreted.


5. What NTM is responsible for a patient's diagnosis of Parkinson's? ANS: Dopamine

dopamine affects balance and coordination, low levels are found in Parkinson's.

6. A surgical patient is post-op after a hernia repair. The patient is given opioids in the
OR and now has a shallow respiratory rate, pinpoint pupils, and is unresponsive to verbal


, stimulation. The PMHNP prescribed naloxone to reverse the effects of the opioids. Where
does Naloxone fall on the agonist spectrum? ANS: Antagonist

7. Medications for schizophrenia target which main neurotransmitter? ANS:
Dopamine

dopamine causes negative and positive symptoms of schizophrenia, medication block
dopamine to reduce these symptoms


8. first generation antipsychotics improve _________ symptoms, and there is a higher
risk of developing _________. ANS: positive, hyperprolactinemia
9. Which medication is a good option for a patient with schizophrenia who also suffers
from insomnia? ANS: Olanzapine
Olanzapine is the best tolerated antipsychotic


10. What brain region is responsible for speech comprehension? ANS: Wernicke's Area

11. Which neurotransmitter may be responsible for a client's symptoms of depression?
SATA
a. increased level of ACH
b. decreased levels of NE
c. increased levels of 5HT
d. decreased levels of histamine
e. increased levels of glutamate ANS: a. increased levels of ACH b. decreased levels of NE
d. decreased levels of histamine


12. Which pathway is associated with hyperprolactemia? ANS: Tuberoinfundibular

13. True or False: Sulfonamides are an example of CYP450 inducer. ANS: False, they are
inhibitors

Información del documento

Subido en
31 de julio de 2026
Número de páginas
15
Escrito en
2025/2026
Tipo
Examen
Contiene
Preguntas y respuestas
$13.49

¿Documento equivocado? Cámbialo gratis Dentro de los 14 días posteriores a la compra y antes de descargarlo, puedes elegir otro documento. Puedes gastar el importe de nuevo.
Escrito por estudiantes que aprobaron
Inmediatamente disponible después del pago
Leer en línea o como PDF

Seller avatar
Los indicadores de reputación están sujetos a la cantidad de artículos vendidos por una tarifa y las reseñas que ha recibido por esos documentos. Hay tres niveles: Bronce, Plata y Oro. Cuanto mayor reputación, más podrás confiar en la calidad del trabajo del vendedor.
MYNET
3.8
(44)
Vendido
232
Seguidores
16
Artículos
1633
Última venta
2 días hace




Por qué los estudiantes eligen Stuvia

Creado por compañeros estudiantes, verificado por reseñas

Calidad en la que puedes confiar: escrito por estudiantes que aprobaron y evaluado por otros que han usado estos resúmenes.

¿No estás satisfecho? Elige otro documento

¡No te preocupes! Puedes elegir directamente otro documento que se ajuste mejor a lo que buscas.

Paga como quieras, empieza a estudiar al instante

Sin suscripción, sin compromisos. Paga como estés acostumbrado con tarjeta de crédito y descarga tu documento PDF inmediatamente.

Student with book image

“Comprado, descargado y aprobado. Así de fácil puede ser.”

Alisha Student

Preguntas frecuentes